Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin

Caspases: Enemies Within

Thornberry, N. A., & Lazebnik, Y. A. (1998) · Science · doi:10.1126/science.281.5381.1312 · Cited by 6,857

Death Receptors: Signaling and Modulation

Ashkenazi, A., & Dixit, V. M. (1998) · Science · doi:10.1126/science.281.5381.1305 · Cited by 5,866

Opposing Effects of ERK and JNK-p38 MAP Kinases on Apoptosis

Xia, Z., Dickens, M., Raingeaud, J., Davis, R. J., & Greenberg, M. E. (1995) · Science · doi:10.1126/science.270.5240.1326 · Cited by 5,273

PD 098059 Is a Specific Inhibitor of the Activation of Mitogen-activated Protein Kinase Kinase in Vitro and in Vivo

Alessi, D. R., Cuenda, A., Cohen, P., Dudley, D. T., & Saltiel, A. R. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.46.27489 · Cited by 3,374

Identification of a Novel Inhibitor of Mitogen-activated Protein Kinase Kinase

Favata, M. F., Horiuchi, K. Y., Manos, E. J., Daulerio, A. J., Stradley, D. A., Feeser, W. S., Dyk, D. E. V., Pitts, W. J., Earl, R. A., Hobbs, F. W., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.29.18623 · Cited by 3,016

The Fire of Life: An Introduction to Animal Energetics

Kleiber, M. (1975) · Medical Entomology and Zoology · Cited by 2,529

A short amino acid sequence able to specify nuclear location

Kalderon, D., Roberts, B., Richardson, W. D., & Smith, A. E. (1984) · Cell · doi:10.1016/0092-8674(84)90457-4 · Cited by 2,511

Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone.

Weinstein, R. S., Jilka, R. L., Parfitt, A. M., & Manolagas, S. C. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2799 · Cited by 1,753 · cited 12×

Nitrogen-Containing Bisphosphonates Inhibit the Mevalonate Pathway and Prevent Post-Translational Prenylation of GTP-Binding Proteins, Including Ras

Luckman, S. P., Hughes, D. E., Coxon, F. P., Russell, R. G. G., & Rogers, M. J. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.4.581 · Cited by 1,176

DNA binding of the glucocorticoid receptor is not essential for survival

Reichardt, H. M., Kaestner, K. H., Tuckermann, J., Kretz, O., Wessely, O., Bock, R., Gass, P., Schmid, W., Herrlich, P., Angel, P., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81183-6 · Cited by 1,068

Addition of bisphosphonate to antibiotic and anti‐inflammatory treatment reduces bone resorption in experimental Staphylococcus aureus‐induced arthritis

Verdrengh, M., Carlsten, H., Ohlsson, C., & Tarkowski, A. (2006) · Journal of Orthopaedic Research® · doi:10.1002/jor.20317 · Cited by 30

An Aromatase Polymorphism (g.132810C>T) Predicts Risk of Bisphosphonate-Related Osteonecrosis of the Jaw

Ferla, F. L., Paolicchi, E., Crea, F., Cei, S., Graziani, F., Gabriele, M., & Danesi, R. (2012) · Biomarkers in Medicine · doi:10.2217/bmm.12.14 · Cited by 30

Prevention and treatment of glucocorticoid-induced osteoporosis in 2005

Orcel, P. (2005) · Joint Bone Spine · doi:10.1016/j.jbspin.2005.09.002 · Cited by 30

Effects of Vitamin K2 on Cortical and Cancellous Bone Mass, Cortical Osteocyte and Lacunar System, and Porosity in Sciatic Neurectomized Rats

Iwamoto, J., Matsumoto, H., Takeda, T., Satō, Y., & Yeh, J. K. (2010) · Calcified Tissue International · doi:10.1007/s00223-010-9387-7 · Cited by 29

Biological options to enhance periprosthetic bone mass

Tsiridis, E. E., Gamie, Z., Conaghan, P. G., & Giannoudis, P. V. (2007) · Injury · doi:10.1016/j.injury.2007.02.051 · Cited by 29

Calcitonin targets extracellular signal-regulated kinase signaling pathway in human cancers

Nakamura, M., Han, B., Nishishita, T., Bai, Y., & Kakudo, K. (2007) · Journal of Molecular Endocrinology · doi:10.1677/jme-07-0036 · Cited by 29

Immobilization of BMP‐2, BMP‐7 and alendronic acid on titanium surfaces: Adhesion, proliferation and differentiation of bone marrow‐derived stem cells

Kämmerer, P. W., Pabst, A. M., Dau, M., Staedt, H., Al‐Nawas, B., & Heller, M. (2019) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.36805 · Cited by 29

Tumour dormancy in inflammatory microenvironment: A promising therapeutic strategy for cancer-related bone metastasis

Hu, W., Zhang, L., Dong, Y., Tian, Z., Chen, Y., & Dong, S. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03572-1 · Cited by 29

An In Vitro Assessment of Fibroblast and Osteoblast Response to Alendronate-Modified Titanium and the Potential for Decreasing Fibrous Encapsulation

Hu, X., Neoh, K. G., Shi, Z., Kang, E. T., & Wang, W. (2013) · Tissue Engineering Part A · doi:10.1089/ten.tea.2012.0218 · Cited by 29

Osteogenic Activity of Locally Applied Small Molecule Drugs in a Rat Femur Defect Model

Cottrell, J. A., Vales, F. M., Schachter, D., Wadsworth, S. A., Gundlapalli, R., Kapadia, R. D., & O'Connor, J. P. (2010) · BioMed Research International · doi:10.1155/2010/597641 · Cited by 29

Timing, rather than the concentration of cyclic AMP, correlates to osteogenic differentiation of human mesenchymal stem cells

Siddappa, R., Doorn, J., Liu, J., Langerwerf, E., Arends, R. J., van Blitterswijk, C., & de Boer, J. (2009) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.246 · Cited by 29

Apoptosis of Bone Cells

Jilka, R. L., Bellido, T., Almeida, M., Plotkin, L. I., O’Brien, C. A., Weinstein, R. S., & Manolagas, S. C. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373884-4.00032-x · Cited by 30

Approaches for Designing new Potent Inhibitors of Farnesyl Pyrophosphate Synthase

Rodríguez, J. B., Falcone, B. N., & Szajnman, S. H. (2016) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2016.1143814 · Cited by 29

Bone Disease in Multiple Myeloma

Eda, H., Santo, L., Roodman, G. D., & Raje, N. S. (2016) · Cancer treatment and research · doi:10.1007/978-3-319-40320-5_14 · Cited by 30

Pharmacological management of X‐linked hypophosphataemia

Imel, E. A., & White, K. E. (2018) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13763 · Cited by 29

Glucocorticoid-Induced Bone Fragility Is Prevented in Female Mice by Blocking Pyk2/Anoikis Signaling

Sato, A. Y., Cregor, M. D., McAndrews, K., Li, T., Condon, K. W., Plotkin, L. I., & Bellido, T. (2019) · Endocrinology · doi:10.1210/en.2019-00237 · Cited by 29

Kinase-mediated transcription, activators of nongenotropic estrogen–like signaling (ANGELS), and osteoporosis: A different perspective on the HRT dilemma

Manolagas, S. C., Kousteni, S., Chen, J., Schuller, M., Plotkin, L. I., & Bellido, T. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.09107.x · Cited by 29

Effects of 1α,25-Dihydroxyvitamin D3 and Growth Hormone on Apoptosis and Proliferation in UMR 106 Osteoblast-Like Cells

Morales, O., Samuelsson, M. K. R., Lindgren, U., & Haldosén, L.-A. (2003) · Endocrinology · doi:10.1210/en.2003-0718 · Cited by 29

The treatment of glucocorticoid-induced osteoporosis

Cohen, D., & Adachi, J. D. (2004) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2004.01.003 · Cited by 29

Tissue culture models for studies of hormone and vitamin action in bone cells

Bodine, P. V. N., & Komm, B. S. (2002) · Vitamins and hormones · doi:10.1016/s0083-6729(02)64004-x · Cited by 29

Bisphosphonates beyond their anti-osteoclastic properties

VARENNA, M. (2013) · Lara D. Veeken · doi:10.1093/rheumatology/ket370 · Cited by 29

Single-Cell Transcriptomic Analysis Identifies Senescent Osteocytes That Trigger Bone Destruction in Breast Cancer Metastasis

Kaur, J., Adhikari, M., Sabol, H. M., Anloague, A., Khan, S., Kurihara, N., Diaz‐delCastillo, M., Andreasen, C. M., Barnes, C. L., Stambough, J. B., et al. (2024) · Cancer Research · doi:10.1158/0008-5472.can-24-0857 · Cited by 34

Rubus coreanusMiq. Extract Promotes Osteoblast Differentiation and Inhibits Bone-Resorbing Mediators in MC3T3-E1 Cells

Lee, K.-H., & Choi, E.-M. (2006) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x0600417x · Cited by 28

Advances in Our Understanding of the Mechanism of Action of Drugs (including Traditional Chinese Medicines) for the Intervention and Treatment of Osteoporosis

Lu, J., Hu, D., Ma, C., & Shuai, B. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.938447 · Cited by 29

Cladrin alleviates dexamethasone-induced apoptosis of osteoblasts and promotes bone formation through autophagy induction via AMPK/mTOR signaling

Rai, R., Singh, K. B., Khanka, S., Maurya, R., & Singh, D. R. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.08.028 · Cited by 29

Electrospun Nanofibers in Tissue Engineering

Mitchell, R., Tanner, K., James, J., & Lee, S. J. (2011) · InTech eBooks · doi:10.5772/24095 · Cited by 28

Weekly clodronate treatment prevents bone loss and vertebral fractures in women with subclinical Cushing’s syndrome

Tauchmanovà, L., Guerra, E., Pivonello, R., Martino, M. C. D., Leo, M. D., Caggiano, F., Lombardi, G., & Colao, A. (2009) · Journal of Endocrinological Investigation · doi:10.1007/bf03346473 · Cited by 28

Bisphosphonate Induced Growth Inhibition of Breast Cancer Cells is Augmented by p38 Inhibition

Merrell, M. A., Suarez‐Cuervo, C., Harris, K. W., Väänänen, H. K., & Selander, K. S. (2003) · Breast Cancer Research and Treatment · doi:10.1023/a:1026126430905 · Cited by 28

Effect of pamidronate on the stimulation of macrophage TNF‐α release by ultra‐high‐molecular‐weight polyethylene particles: a role for apoptosis

Huk, O. L., Zukor, D. J., Antoniou, J., & Petit, A. (2002) · Journal of Orthopaedic Research® · doi:10.1016/s0736-0266(02)00099-2 · Cited by 28

Molecular determinants of glucocorticoid actions in inflammatory joint diseases

Baschant, U., Culemann, S., & Tuckermann, J. P. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.06.009 · Cited by 29

Cancellous bone formation response to simulated resistance training during disuse is blunted by concurrent alendronate treatment

Swift, J. M., Swift, S. N., Nilsson, M. I., Hogan, H. A., Bouse, S. D., & Bloomfield, S. A. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.407 · Cited by 28

Vanadate prevents glucocorticoid-induced apoptosis of osteoblasts in vitro and osteocytes in vivo

Conradie, M., de Wet, H., Kotze, D., Burrin, J. M., Hough, F. S., & Hulley, P. A. (2007) · Journal of Endocrinology · doi:10.1677/joe-07-0217 · Cited by 28

Incadronate Amplifies Prostaglandin F2α-induced Vascular Endothelial Growth Factor Synthesis in Osteoblasts

Tokuda, H., Harada, A., Hirade, K., Matsuno, H., Ito, H., Kato, K., Oiso, Y., & Kozawa, O. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209159200 · Cited by 28

American Society of Biomechanics Journal of Biomechanics Award 2013: Cortical bone tissue mechanical quality and biological mechanisms possibly underlying atypical fractures

Geissler, J. R., Bajaj, D., & Fritton, J. C. (2015) · Journal of Biomechanics · doi:10.1016/j.jbiomech.2015.01.032 · Cited by 27

Alendronate and raloxifene affect the osteoprotegerin/RANKL system in human osteoblast primary cultures from patients with osteoporosis and osteoarthritis

Giner, M., Rios, M. J., Montoya, M. J., Vázquez, M. Á., Miranda, C., & Pérez‐Cano, R. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.10.058 · Cited by 25

99mTC-Methylene diphosphonate uptake at injury site correlates with osteoblast differentiation and mineralization during bone healing in mice

Zhong, Z. A., Peck, A. S., Li, S., Oss, J. V., Snider, J., Droscha, C. J., Chang, T.-T. A., & Williams, B. O. (2015) · Bone Research · doi:10.1038/boneres.2015.13 · Cited by 27

Ibandronate: Pharmacology and preclinical studies

Russell, R. G. G. (2006) · Bone · doi:10.1016/j.bone.2006.01.151 · Cited by 27

Effects of a single infusion of pamidronate prior to liver transplantation: a bone histomorphometric study

Vedi, S., Ninkovic, M., Garrahan, N. J., Alexander, G., & Compston, J. E. (2002) · Transplant International · doi:10.1111/j.1432-2277.2002.tb00167.x · Cited by 27

Does locally delivered Zoledronate influence peri-implant bone formation? – Spatio-temporal monitoring of bone remodeling in vivo

Kettenberger, U., Ston, J., Thein, E., Procter, P., & Pioletti, D. P. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.09.005 · Cited by 26

Bisphosphonates inhibit surface‐mediated osteogenesis

Lotz, E. M., Lohmann, C. H., Boyan, B. D., & Schwartz, Z. (2020) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.36944 · Cited by 27

DCAF1-targeting microRNA-3175 activates Nrf2 signaling and inhibits dexamethasone-induced oxidative injury in human osteoblasts

Chen, J., Liang, J., Zhen, Y.-F., Chang, L., Zhou, Z., & Shen, X. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04300-8 · Cited by 26

Lactoferrin inhibits apoptosis through insulin-like growth factor I in primary rat osteoblasts

Hou, J.-M., Chen, E.-Y., Wei, S., Lin, F., Lin, Q.-M., Lan, X.-H., Xue, Y., & Wu, M. (2014) · Acta Pharmacologica Sinica · doi:10.1038/aps.2013.173 · Cited by 28

The effect of the alendronate on OPG/RANKL system in differentiated primary human osteoblasts

Enjuanes, A., Ruiz-Gaspà, S., Peris, P., Ozalla, D., Álvarez, L., Combalía, A., de Osaba, M. J. M., Monegal, A., Parés, A. R., & Guañabens, N. (2009) · Endocrine · doi:10.1007/s12020-009-9285-9 · Cited by 26

Calcitonin inhibits invasion of breast cancer cells: Involvement of urokinase-type plasminogen activator (uPA) and uPA receptor

Han, B., Nakamura, M., Zhou, G., Ishii, A., Nakamura, A., Bai, Y., Mori, I., & Kakudo, K. (2006) · International Journal of Oncology · doi:10.3892/ijo.28.4.807 · Cited by 26

The Osteocyte

Klein‐Nulend, J., & Bonewald, L. F. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373884-4.00028-8 · Cited by 26

Osteonekrose der Kiefer unter Bisphosphonat-Langzeittherapie

Piesold, J.-U., Al‐Nawas, B., & Grötz, K. A. (2006) · Oral and Maxillofacial Surgery · doi:10.1007/s10006-006-0017-5 · Cited by 26

Calcitonin Promotes Outgrowth of Trophoblast Cells on Endometrial Epithelial Cells: Involvement of Calcium Mobilization and Protein Kinase C Activation

Li, H.-Y., Shen, J.-T., Chang, S.-P., Hsu, W.-L., & Sung, Y.-J. (2007) · Placenta · doi:10.1016/j.placenta.2007.09.012 · Cited by 26

Alendronate Stimulates Collagenase 3 Expression in Osteoblasts by Posttranscriptional Mechanisms

Varghese, S., & CANALIS, E. M. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.12.2345 · Cited by 27

The effect of alendronate soaking and ultraviolet treatment on bone–implant interface

Kim, H. S., Lee, J. I., Yang, S. S., Kim, B., Kim, B.-C., & Lee, J. (2016) · Clinical Oral Implants Research · doi:10.1111/clr.12933 · Cited by 25

The diagnosis and management of spontaneous and post-arthroscopy osteonecrosis of the knee.

Strauss, E. J., Kang, R. W., Bush‐Joseph, C. A., & Bach, B. R. (2011) · PubMed · Cited by 25

The Effect of Local Delivery Doxycycline and Alendronate on Bone Repair

Limírio, P. H. J. O., Rocha, F. S., Batista, J. D., Henriques, J. C. G., de Melo, G. B., & Dechichi, P. (2015) · AAPS PharmSciTech · doi:10.1208/s12249-015-0411-0 · Cited by 25

Osteonecrosis of the Jaw—a Bone Site-Specific Effect of Bisphosphonates

Vermeer, J. A. F., Renders, G. A. P., & Everts, V. E. (2016) · Current Osteoporosis Reports · doi:10.1007/s11914-016-0318-z · Cited by 24

Aging of the Bone

Wei, Y., & Sun, Y. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-1117-8_12 · Cited by 25

Bisphosphonate treatment of pediatric bone disease.

Speiser, P., Clarson, C. L., Eugster, E. A., Kemp, S. F., Radovick, S., Rogol, A. D., & Wilson, T. A. (2005) · PubMed · Cited by 25

In vitro response of hFOB cells to pamidronate modified sodium silicate coated cellulose scaffolds

Ponader, S., Brandt, H., Vairaktaris, E. G., von Wilmowsky, C., Nkenke, E., Schlegel, K. A., Neukam, F. W., Holst, S., Müller, F. A., & Greil, P. (2008) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2008.02.002 · Cited by 25

Selective in vitro antioxidant properties of bisphosphonates

Dombrecht, E. J., Cos, P., Berghe, D. V., Offel, J. F. V., Schuerwegh, A. J., Bridts, C. H., Stevens, W. J., & De Clerck, L. S. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.12.149 · Cited by 23

Ibandronate increases the expression of the pro-apoptotic gene FAS by epigenetic mechanisms in tumor cells

Thaler, R., Spitzer, S., Karlic, H., Berger, C., Klaushofer, K., & Varga, F. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.10.016 · Cited by 24

Structural Biology of Calcitonin: From Aqueous Therapeutic Properties to Amyloid Aggregation

Kamgar‐Parsi, K., Tolchard, J. L., Habenstein, B., Loquet, A., Naito, A., & Ramamoorthy, A. (2016) · Israel Journal of Chemistry · doi:10.1002/ijch.201600096 · Cited by 25

Endogenous Glucocorticoid Metabolism in Bone: Friend or Foe

Martin, C., Cooper, M. S., & Hardy, R. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.733611 · Cited by 24

Fine‐tuning osteoclastogenesis: An insight into the cellular and molecular regulation of osteoclastogenesis

Anwar, A., Sapra, L., Gupta, N., Ojha, R. P., Verma, B., & Srivastava, R. K. (2023) · Journal of Cellular Physiology · doi:10.1002/jcp.31036 · Cited by 26

Controlled Delivery of Zoledronate Improved Bone Formation Locally In Vivo

Gou, W., Wang, X., Peng, J. C., Lu, Q., Wang, Y., Wang, Y., Guo, Q., Gao, X., Xu, W., & Lu, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091317 · Cited by 24

Coupling Hydroxyapatite Nanocrystals with Lactoferrin as a Promising Strategy to Fine Regulate Bone Homeostasis

Montesi, M., Panseri, S., Iafisco, M., Adamiano, A., & Tampieri, A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132633 · Cited by 25

Hypoxia mediates osteocyte ORP150 expression and cell death in vitro

Montesi, M., Jähn, K., Bonewald, L. F., Stea, S., Bordini, B., & Beraudi, A. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5790 · Cited by 25

Enhanced Osteogenic Differentiation in Zoledronate-Treated Osteoporotic Patients

Carbonare, L. D., Mottes, M., Malerba, G., Mori, A., Zaninotto, M., Plebani, M., Dellantonio, A., & Valenti, M. T. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18061261 · Cited by 24

Mechanical Induction of BMP-7 in Osteocyte Blocks Glucocorticoid-Induced Apoptosis Through PI3K/AKT/GSK3β Pathway

Wang, Z., & Guo, J. (2013) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-013-9543-6 · Cited by 24

Promotion of osteoclast survival and antagonism of bisphosphonate-induced osteoclast apoptosis by glucocorticoids

Weinstein, R. S., Chen, J., Powers, C. C., Stewart, S. A., Landes, R. D., Bellido, T., Jilka, R. L., PARFITT, A. M., & Manolagas, S. C. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200214538 · Cited by 25

Role of osteogenic Dickkopf-1 in bone remodeling and bone healing in mice with type I diabetes mellitus

Hildebrandt, N., Colditz, J., Dutra, C., Góes, P., Salbach‐Hirsch, J., Thiele, S., Hofbauer, L. C., & Rauner, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-81543-7 · Cited by 24

A systematic review of microsurgical reconstruction of the jaws using vascularized fibula flap technique in patients with bisphosphonate-related osteonecrosis

Sacco, R., Sacco, G., Acocella, A., Sale, S., Sacco, N., & Baldoni, E. (2011) · Journal of Applied Oral Science · doi:10.1590/s1678-77572011000400001 · Cited by 23

Effect of D-003, a Mixture of Very High Molecular Weight Aliphatic Acids, on Prednisolone-Induced Osteoporosis in Sprague-Dawley Rats

Noa, M., Mendoza, S., s, R. M., Mendoza, N., & Le??n, F. (2004) · Drugs in R&D · doi:10.2165/00126839-200405050-00004 · Cited by 23

Bisphosphonate protonation states, conformations, and dynamics on bone mineral probed by solid-state NMR without isotope enrichment

Ironside, M. S., Duer, M. J., Reid, D. G., & Byard, S. J. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.05.013 · Cited by 23

Local application of zoledronate enhances miniscrew implant stability in dogs

Cuairán, C., Campbell, P. M., Kontogiorgos, E. D., Taylor, R. W., Melo, A. C. M., & Buschang, P. H. (2014) · American Journal of Orthodontics and Dentofacial Orthopedics · doi:10.1016/j.ajodo.2014.01.020 · Cited by 23

Etidronate inhibits human osteoblast apoptosis by inhibition of pro-apoptotic factor(s) produced by activated T cells

Abe, Y., Kawakami, A., Nakashima, T., Ejima, E., Fujiyama, K., Kiriyama, T., Ide, A., Sera, N., Usa, T., Tominaga, T., et al. (2000) · Journal of Laboratory and Clinical Medicine · doi:10.1067/mlc.2000.109757 · Cited by 23

Stiffness and strength of bone in osteoporotic patients treated with varying durations of oral bisphosphonates

Ward, J. J., Wood, C. L., Rouch, K. E., Pienkowski, D., & Malluche, H. H. (2016) · Osteoporosis International · doi:10.1007/s00198-016-3661-0 · Cited by 23

Connexin37 deficiency alters organic bone matrix, cortical bone geometry, and increases Wnt/β-catenin signaling

Pacheco‐Costa, R., Kadakia, J. R., Atkinson, E. G., Wallace, J. M., Plotkin, L. I., & Reginato, R. D. (2017) · Bone · doi:10.1016/j.bone.2017.01.010 · Cited by 23

Osteoblastic cell secretome: A novel role for progranulin during risedronate treatment

Romanello, M., Piatkowska, E. M., Antoniali, G., Cesaratto, L., Vascotto, C., Iozzo, R. V., Delneri, D., & Brancia, F. L. (2013) · Bone · doi:10.1016/j.bone.2013.10.003 · Cited by 23

Effects of Risedronate, Alendronate, and Etidronate on the Viability and Activity of Rat Bone Marrow Stromal Cells In Vitro

Still, K., Phipps, R. J., & Scutt, A. M. (2003) · Calcified Tissue International · doi:10.1007/s00223-001-2066-y · Cited by 23

Incadronate and Etidronate Accelerate Phosphate-Primed Mineralization of MC4 Cells via ERK1 /2-Cbfa1 Signaling Pathway in a Ras-Independent Manner: Further Involvement of Mevalonate-Pathway Blockade for Incadronate

Fujita, T., Izumo, N., Fukuyama, R., Meguro, T., Yasutomi, C., Nakamuta, H., & Koida, M. (2001) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.86.86 · Cited by 23

Role of bisphosphonates in the management of acute Charcot foot

Durgia, H., Sahoo, J., Kamalanathan, S., Palui, R., Sridharan, K., & Raj, H. (2018) · World Journal of Diabetes · doi:10.4239/wjd.v9.i7.115 · Cited by 22

Osteocytic miR21 deficiency improves bone strength independent of sex despite having sex divergent effects on osteocyte viability and bone turnover

Davis, H. M., Deosthale, P. J., Pacheco‐Costa, R., Essex, A. L., Atkinson, E. G., Aref, M. W., Dilley, J. E., Bellido, T., Ivan, M., Allen, M. R., et al. (2019) · FEBS Journal · doi:10.1111/febs.15066 · Cited by 20

Pathways Controlling Formation and Maintenance of the Osteocyte Dendrite Network

Wang, J. S., & Wein, M. N. (2022) · Current Osteoporosis Reports · doi:10.1007/s11914-022-00753-8 · Cited by 26

Management of glucocorticoid-induced osteoporosis: prevalence, and emerging treatment options

Payer, J. (2010) · Drug Healthcare and Patient Safety · doi:10.2147/dhps.s7197 · Cited by 22

Bisphosphonates in the treatment of metabolic bone diseases

Arantes, H. P., da Silva, A. G., & Lazaretti‐Castro, M. (2010) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302010000200017 · Cited by 21

Association Between Osteonecrosis of the Jaws and Chronic High-Dosage Intravenous Bisphosphonates Therapy

Graziani, F., Cei, S., Ferla, F. L., Cerri, E., Itro, A., & Gabriele, M. (2006) · Journal of Craniofacial Surgery · doi:10.1097/01.scs.0000221517.80361.6f · Cited by 22

Zoledronate for Osteogenesis imperfecta: evaluation of safety profile in children

Kumar, C., Panigrahi, I., Aradhya, A. S., Meena, B. L., & Khandelwal, N. K. (2016) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2015-0351 · Cited by 22

Cytoprotective effect of flavonoid‐induced autophagy on bisphosphonate mediated cell death in osteoblast

Kim, J., Kang, H., Yu, S., Song, J., Kim, C., Kim, B., Park, B.-S., Shin, S., & Kim, I. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26728 · Cited by 22

Effect of Raloxifene Treatment on Osteocyte Apoptosis in Postmenopausal Women

van Essen, H. W., Holzmann, P. J., Blankenstein, M. A., Lips, P. T. A. M., & Bravenboer, N. (2007) · Calcified Tissue International · doi:10.1007/s00223-007-9050-0 · Cited by 22

Densitometric Threshold and Vertebral Fractures in Heart Transplant Patients

Carbonare, L. D., Zanatta, M., Braga, V., Sella, S., Vilei, M. T., Feltrin, G., Gambino, A., Pepe, I., Rossini, M., Adami, S., et al. (2011) · Transplantation · doi:10.1097/tp.0b013e31821cdeef · Cited by 22

In vitro kinetic study of growth and mineralization of osteoblast‐like cells (Saos‐2) on titanium surface coated with a RGD functionalized bisphosphonate

Beuvelot, J., Portet, D., Lecollinet, G., Moreau, M., Baslé, M. F., Chappard, D., & Libouban, H. (2009) · Journal of Biomedical Materials Research Part B Applied Biomaterials · doi:10.1002/jbm.b.31357 · Cited by 22

Steroid-free medium discloses oestrogenic effects of the bisphosphonate clodronate on breast cancer cells

Journé, F., Chaboteaux, C., Dumon, J. C., Leclercq, G., Laurent, G., & Body, J. J. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602181 · Cited by 22

Ibandronate Treatment Before and After Implant Insertion Impairs Osseointegration in Aged Rats with Ovariectomy Induced Osteoporosis

Lotz, E. M., Cohen, D. J., Ellis, R. A., Wayne, J. S., Schwartz, Z., & Boyan, B. D. (2019) · JBMR Plus · doi:10.1002/jbm4.10184 · Cited by 24

CCL7 Is a Protective Factor Secreted by Mechanically Loaded Osteocytes

Kitase, Y., Lee, S., Gluhak‐Heinrich, J., Johnson, M. L., Harris, S. E., & Bonewald, L. F. (2014) · Journal of Dental Research · doi:10.1177/0022034514553008 · Cited by 20

Transcriptome and Proteome Analysis of Osteocytes Treated with Nitrogen-Containing Bisphosphonates

Bivi, N., Bereszczak, J. Z., Romanello, M., Zeef, L. A. H., Delneri, D., Quadrifoglio, F., Moro, L., Brancia, F. L., & Tell, G. (2009) · Journal of Proteome Research · doi:10.1021/pr8005606 · Cited by 21

Effects of the bisphosphonate risedronate on osteopenia in OASIS-deficient mice

Sekiya, H., Murakami, T., Saito, A., Hino, S.-I., Tsumagari, K., Ochiai, K., & Imaizumi, K. (2009) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-009-0142-y · Cited by 21

Prevention of aortic valve stenosis: A realistic therapeutic target?

Ngo, D. T. M., Sverdlov, A. L., & Horowitz, J. D. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.04.001 · Cited by 21

Glucocorticoid-induced osteoporosis: hope on the HORIZON

Gennari, L., & Bilezikian, J. P. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60704-2 · Cited by 21

There are many potential medical therapies for atraumatic osteonecrosis

Fessel, J. (2012) · Rheumatology · doi:10.1093/rheumatology/kes241 · Cited by 21

Ca2+-Dependent Regulation of Calcitonin Gene Expression by the Transcriptional Repressor DREAM

Matsuda, M., Yamamoto, T.-A., & Hirata, M. (2006) · Endocrinology · doi:10.1210/en.2006-0254 · Cited by 21

High glucose alters the secretome of mechanically stimulated osteocyte‐like cells affecting osteoclast precursor recruitment and differentiation

Maycas, M., Portolés, M. T., Matesanz, M. C., Buendía, I., Linares, J., Feito, M. J., Arcos, D., Vallet‐Regí, M., Plotkin, L. I., Esbrit, P., et al. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.25829 · Cited by 21

Risk of atypical femoral fracture with long-term use of alendronate (bisphosphonates) : a systemic review of literature.

Agarwal, S., Agarwal, S., Gupta, P., Agarwal, P. K., Agarwal, G., & Bansal, A. (2010) · PubMed · Cited by 21

A bisphosphonate that does not affect osteoclasts prevents osteoblast and osteocyte apoptosis and the loss of bone strength induced by glucocorticoids in mice

Plotkin, L. I., Bivi, N., & Bellido, T. (2010) · Bone · doi:10.1016/j.bone.2010.08.011 · Cited by 81

BISPHOSPHONATES INHIBIT GLUCOCORTICOID INDUCED DEATH IN OSTEOCYTES

Kogianni, G., Stevens, H. Y., Rogers, M. J., Wheeler-Jones, C. P. D., & Noble, B. (2003) · Orthopaedic Proceedings

Promotion of osteoclast survival and antagonism of bisphosphonate-induced osteoclast apoptosis by glucocorticoids

Weinstein, R. S., Chen, J., Powers, C. C., Stewart, S. A., Landes, R. D., Bellido, T., Jilka, R. L., PARFITT, A. M., & Manolagas, S. C. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14538 · Cited by 397

Dissociation of the pro-apoptotic effects of bisphosphonates on osteoclasts from their anti-apoptotic effects on osteoblasts/osteocytes with novel analogs

Plotkin, L. I., Manolagas, S. C., & Bellido, T. (2006) · Bone · doi:10.1016/j.bone.2006.02.060 · Cited by 166

Calcitonin Inhibits SDCP-Induced Osteoclast Apoptosis and Increases Its Efficacy in a Rat Model of Osteoporosis

Kuo, Y., Tsuang, F.-Y., Sun, J., Lin, C.-H., Chen, C.-H., Li, J.-Y., Huang, Y.-C., Chen, W., Yeh, C., & Shyu, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040272 · Cited by 28